Can CM‑Glucan (beta‑glucan) cause gastrointestinal upset in a 10‑year‑old boy with dengue on day 3 who is afebrile and without warning signs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can CM-Glucan (Beta-Glucan) Cause Gastrointestinal Upset?

Beta-glucan supplements are generally well-tolerated in children with minimal gastrointestinal side effects, and are unlikely to be causing stomach upset in this 10-year-old boy with dengue. 1, 2

Safety Profile in Pediatric Populations

  • Ten out of twelve clinical trials in children reported good tolerance and safety profiles for beta-glucan supplementation, with doses ranging from 10 mg/5 kg body weight/day up to 75 mg/day. 1
  • The most common beta-glucan preparations studied in children (pleuran and baker's yeast beta-glucan) demonstrated favorable benefit-risk ratios with minimal adverse effects reported. 1
  • Beta-glucan is classified as a natural dietary fiber with low risk of toxicity, even at high doses. 1, 2

Gastrointestinal Effects of Beta-Glucan

  • Dietary fiber sources including beta-glucan can theoretically cause mild gastrointestinal symptoms, but this is primarily documented with very high doses (>10 grams) of certain fiber types like guar gum, not the immunomodulatory doses used in supplements. 3
  • No significant gastrointestinal adverse effects were reported in pediatric trials of beta-glucan supplementation, even in studies lasting up to 6 months. 1
  • Beta-glucan's mechanism as a soluble fiber primarily affects cholesterol metabolism and immune function rather than causing direct gastrointestinal irritation. 3, 2

Alternative Explanation: Dengue-Related Symptoms

The gastrointestinal symptoms are far more likely related to the dengue infection itself rather than beta-glucan supplementation. 4

  • Abdominal pain and gastrointestinal symptoms occur in up to 40% of children with dengue, particularly those developing warning signs. 3
  • Dengue infection causes modest intestinal permeability defects (leaky gut syndrome) that are associated with gastrointestinal symptoms, especially in patients who progress to severe disease. 4
  • Serum beta-D-glucan levels (a biomarker, not the supplement) are elevated in severe dengue patients due to intestinal barrier dysfunction, with levels reaching 123 pg/mL versus 73.8 pg/mL in non-severe cases. 4
  • 91% of dengue patients with warning signs demonstrated positive intestinal permeability tests, indicating that gut dysfunction is a hallmark of dengue pathophysiology. 4

Clinical Recommendation

  • Continue the beta-glucan supplement as it has demonstrated immune-modulating properties that may be beneficial during viral infections, with excellent safety data in children. 1, 2
  • Monitor closely for dengue warning signs including persistent vomiting, severe abdominal pain, clinical fluid accumulation, mucosal bleeding, lethargy, liver enlargement, or rising hematocrit with falling platelets. 4
  • The gastrointestinal symptoms should be attributed to the dengue infection and managed accordingly, not to the beta-glucan supplement. 4
  • If gastrointestinal symptoms worsen significantly, this represents potential progression to severe dengue requiring immediate medical evaluation, not a supplement reaction. 4

Important Caveat

  • While beta-glucan exposure through certain routes (particularly airborne) might induce inflammatory responses, oral supplementation in standard doses has not been associated with adverse gastrointestinal effects in pediatric studies. 5, 1

References

Research

The anti-infective effect of β-glucans in children.

International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 2024

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Beta Glucan Immunomodulation Evidence

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.